ResearcherID Clarivate Analytics  

Pritchard, Kathleen I
Create a ResearcherID badge for this researcher View publications analytics for this researcher
Close
ResearcherID: I-2184-2014
URL: http://www.researcherid.com/rid/I-2184-2014
Subject: Oncology
Keywords: breast cancer; clinical trial; prognostic, predicitive, diagnostic, survival; medical oncology; tissue bank
ORCID: http://orcid.org/0000-0003-0758-9666
My Institutions (more details)
Primary Institution:
Sub-org/Dept: Sunnybrook Odette Cancer Centre
Role:
 
 

This list contains papers that I have authored.

publication(s)  
First Page Previous Page Page   of  26  Go Next Page Last Page
  Sort by:    Results per page: 
1.  Title: Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial
 Author(s): Goss, P. E.; Hershman, D. L.; Cheung, A. M.; et al.
 Source: Lancet Oncology Volume: 15 Issue: 4 Pages: 474-482 Published: 2014
 Times Cited: 21
 DOI: 10.1016/s1470-2045(14)70035-x
added
08-Jul-14
2.  Title: Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2
 Author(s): Rugo, H. S.; Pritchard, K. I.; Gnant, M.; et al.
 Source: Annals of Oncology Volume: 25 Issue: 4 Pages: 808-815 Published: 2014
 Times Cited: 71
 DOI: 10.1093/annonc/mdu009
added
08-Jul-14
3.  Title: Predicting anthracycline benefit: TOP2A and CEP17-not only but also
 Author(s): Bartlett, J. M. S.; McConkey, C. C.; Munro, A. F.; et al.
 Source: European Journal of Cancer Volume: 50 Pages: S164 Published: 2014
 Times Cited: 0
added
08-Jul-14
4.  Title: Tumor factors predictive of response to hypofractionated radiotherapy in a randomized trial following breast conserving therapy
 Author(s): Bane, A. L.; Whelan, T. J.; Pond, G. R.; et al.
 Source: Annals of Oncology Volume: 25 Issue: 5 Pages: 992-998 Published: 2014
 Times Cited: 31
 DOI: 10.1093/annonc/mdu090
added
08-Jul-14
5.  Title: Effect of Everolimus on Bone Marker Levels and Progressive Disease in Bone in BOLERO-2
 Author(s): Gnant, M.; Baselga, J.; Rugo, H. S.; et al.
 Source: Jnci-Journal of the National Cancer Institute Volume: 105 Issue: 9 Pages: 654-663 Published: 2013
 Times Cited: 45
 DOI: 10.1093/jnci/djt026
added
08-Jul-14
6.  Title: Effect of visceral metastases on the efficacy and safety of everolimus in postmenopausal women with advanced breast cancer: Subgroup analysis from the BOLERO-2 study
 Author(s): Campone, M.; Bachelot, T.; Gnant, M.; et al.
 Source: European Journal of Cancer Volume: 49 Issue: 12 Pages: 2621-2632 Published: 2013
 Times Cited: 34
 DOI: 10.1016/j.ejca.2013.04.011
added
08-Jul-14
7.  Title: Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial
 Author(s): Burris, H. A.; Lebrun, F.; Rugo, H. S.; et al.
 Source: Cancer Volume: 119 Issue: 10 Pages: 1908-1915 Published: 2013
 Times Cited: 59
 DOI: 10.1002/cncr.28010
added
08-Jul-14
8.  Title: Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases: the state of the art
 Author(s): Clemons, M.; Gelmon, K. A.; Pritchard, K. I.; et al.
 Source: Current Oncology Volume: 19 Issue: 5 Pages: 259-268 Published: 2012
 Times Cited: 37
 DOI: 10.3747/co.19.1011
added
08-Jul-14
9.  Title: Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
 Author(s): Albain, K.; Anderson, S.; Arriagada, R.; et al.
 Source: Lancet Volume: 379 Issue: 9814 Pages: 432-444 Published: 2012
 Times Cited: 744
 DOI: 10.1016/s0140-6736(11)61625-5
added
08-Jul-14
10.  Title: Everolimus Added to Exemestane Reduced Bone Markers and Disease Progression in Bone in Postmenopausal Women with Advanced Breast Cancer: Updated Results From the BOLERO-2 Trial
 Author(s): Gnant, M.; Hortobagyi, G. N.; Rugo, H.; et al.
 Source: European Journal of Cancer Volume: 48 Pages: S2 Published: 2012
 Times Cited: 0
added
08-Jul-14
publication(s)  
First Page Previous Page Page   of  26  Go Next Page Last Page
  Sort by:    Results per page: